Krishnan Suma's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Apr 18, 2023
- Accession no.
- 0001298711-23-000012
- Filed
- Apr 18, 2023
- Trade date
- Apr 17, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions. Open-market sales total $4.38M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krishnan SumaCIK 0001298711 | Director, Officer (President, R&D), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | Common Stock | SSaleDisposed | −1,050 | $85.55F2 | −$89,827.5 | 1,673,156 | Direct | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −4,297 | $86.80F3 | −$372,979.6 | 1,668,859 | Direct | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −9,429 | $87.41F4 | −$824,188.89 | 1,659,430 | Direct | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −9,724 | $88.41F5 | −$859,698.84 | 1,649,706 | Direct | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −500 | $89.12F6 | −$44,560 | 1,649,206 | Direct | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −1,050 | $85.55F2 | −$89,827.5 | 1,737,638 | Indirect | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −4,298 | $86.80F3 | −$373,066.4 | 1,733,340 | Indirect | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −9,428 | $87.41F4 | −$824,101.48 | 1,723,912 | Indirect | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −9,724 | $88.41F5 | −$859,698.84 | 1,714,188 | Indirect | |
| Apr 17, 2023 | Common Stock | SSaleDisposed | −500 | $89.12F6 | −$44,560 | 1,713,688 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F3
The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F4
The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F5
The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.
- F6
The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 2 transactions in Table I.